特应性皮炎（Atopic Dermatitis, AD）是一种令人困扰的慢性皮肤病，很多人可能会问：它究竟是什么病？为何有些人在公共场合也无法控制瘙痒？面对中重度特应性皮炎的患者，他们的生活又是怎样的？ 特应性皮炎的病因复杂，主要与皮肤屏障功能受损、免疫系统失调以及神经系统相互作用有关。根据复旦大学附属华山医院的顾超颖教授，特应性皮炎是一种复发性炎症性疾病，全球有超过2.3亿人受到其影响。在中国， ...

For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study ...

Corvus' soquelitinib shows potential in atopic dermatitis, with key clinical milestones by 2025. Read here to know why we are ...

For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study published online July 15 in the American Journal of Clinical Dermatology. Andrew ...

USA: Atopic eczema (AE), including AE severity, is linked with a decreasing lymphocyte count, regardless of the use of the ...

Patients with moderate to severe and severe alopecia areata have a greater burden of comorbid atopic dermatitis than those with mild alopecia areata.

Children with moderate/more extensive atopic dermatitis treated with ruxolitinib cream achieved significant disease control ...

Dupilumab use for atopic dermatitis and other conditions was associated with an increased risk of incident psoriasis but not psoriatic arthritis.

Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, ...